scholarly journals Emu oil offers protection in Crohn’s disease model in rats

Author(s):  
Bhaskar Vemu ◽  
S. Selvasubramanian ◽  
V. Pandiyan
2018 ◽  
Vol 96 (7) ◽  
pp. 662-667 ◽  
Author(s):  
Amna Naser ◽  
Ahmad Qasem ◽  
Saleh A. Naser

Patients with Crohn’s disease (CD) have higher risk for osteoporosis following decreased level of osteocalcin. We hypothesize that active inflammation following Mycobacterium avium subsp. paratuberculosis (MAP) infection results in elevation of undercarboxylated osteocalcin (ucOC) and downregulation of active osteocalcin in CD patients and cow-disease model (Johne’s disease). In this study, we measured ucOC, active osteocalcin, and calcium levels in sera from 42 cattle (21 infected with MAP and 21 healthy cattle), 18 CD patients, and 20 controls. The level of ucOC in MAP+ bovine samples was higher than that in MAP− controls (318 ± 57.2 nmol/mL vs. 289 ± 95.8 nmol/mL, P > 0.05). Consequently, mean calcium level in bovine MAP+ was significantly higher than that in bovine-MAP− samples (9.98 ± 0.998 mg/dL vs. 7.65 ± 2.12 mg/dL, P < 0.05). Also, the level of ucOC was higher in CD-MAP+ than in CD-MAP− (561 ± 23.7 nmol/mL vs. 285 ± 19.6 nmol/mL, P < 0.05). Interestingly, the mean osteocalcin level in MAP+ bovine was lower than that in MAP− bovine (797 ± 162 pg/mL vs. 1190 ± 43 pg/mL) and it was lower in CD-MAP+ than in CD-MAP− infection (1.89 ± 0.184 ng/mL vs. 2.19 ± 0.763 ng/mL) (P < 0.05). The correlation between MAP infection and elevation of sera ucOC, reduction of active osteocalcin and increased calcium supports MAP infection role in CD and complications with osteoporosis.


2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S254-S255
Author(s):  
U Coskun ◽  
K Kelly ◽  
T Hunter ◽  
L Newton ◽  
T Symonds ◽  
...  

Abstract Background Crohn’s disease (CD) is a type of inflammatory bowel disease that can occur at any age. CD symptoms can have a significant impact on health-related quality of life (HRQL). Although key symptoms and impacts of CD in adults are well-known, they have not been well explored or documented in children and adolescents. The objective of this study was to explore the similarities and differences in CD symptoms and impacts across various age groups (children and adolescents) and develop a list of most common symptoms and impacts for these populations. Methods Children (ages 5–11 years) and adolescents (ages 12–17 years) with CD and parents/caregivers of children with CD (ages 2–11 years) were recruited from US medical practices. Qualitative semi-structured interview guides were developed, informed by published literature. Face-to-face and telephone concept elicitation interviews were conducted, audio-recorded, and transcribed. Transcripts were analysed using thematic methods facilitated by NVivo. Results A total of 49 individuals participated in this study (child n = 11, adolescents n = 20, parents/caregivers n = 18). Preliminary results showed that there was a high level of qualitative agreement between CD symptoms in children and adolescents. The ranking of the top 15 symptoms was nearly identical between the two cohorts. The most frequently discussed symptoms (discussed by ≥75% of the participants in each cohort) were feeling gassy, abdominal pain, diarrhoea, incomplete evacuation, tiredness, and urgency. The second most frequently discussed symptoms (discussed by ≥50% of the participants in each cohort) were cramping, constipation, blood in stool, and frequent bowel movement. While abdominal cramping and blood in stool were discussed by ≥75% of the adolescents, 63% and 50% of the children discussed them respectively. Similarly, while bloating and nausea were discussed by ≥50% of adolescents, 38% and 25% of children discussed them, respectively. Finally, while vomiting was discussed by 50% of the children, 33% of the adolescents discussed it. Impacts due to CD were also regularly discussed across both cohorts but less so by the children. School and low mood/sadness were discussed by ≥50% of the participants in each cohort. Exercise/sport, play/leisure activities, annoyance/frustration, and eating/drinking limitations were discussed by ≥50% of the adolescents but &lt;50% of the children. Conclusion The results from the CE interviews show the clear burden of CD and that this is mostly similar across children and adolescents allowing for a future unified disease model to be developed.


2020 ◽  
Vol 158 (6) ◽  
pp. S-786
Author(s):  
Hiroko Takagi ◽  
Masayoshi Sato ◽  
Kazuyuki Fujii ◽  
Isao Shibuya ◽  
Daisuke Oka ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (11) ◽  
pp. e50630 ◽  
Author(s):  
Susan E. Alters ◽  
Bryant McLaughlin ◽  
Benjamin Spink ◽  
Tigran Lachinyan ◽  
Chia-wei Wang ◽  
...  

2011 ◽  
Vol 140 (5) ◽  
pp. S-519 ◽  
Author(s):  
Jolanta Skarbaliene ◽  
Yvette M. Petersen ◽  
Kennet N. Christjansen ◽  
Kirsten Ebbehoej ◽  
Henrik D. Pedersen ◽  
...  

Metabolomics ◽  
2020 ◽  
Vol 16 (4) ◽  
Author(s):  
Yosuke Komatsu ◽  
Yu Shimizu ◽  
Megumi Yamano ◽  
Mani Kikuchi ◽  
Kiminori Nakamura ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (6) ◽  
Author(s):  
Susan E. Alters ◽  
Bryant McLaughlin ◽  
Benjamin Spink ◽  
Tigran Lachinyan ◽  
Chia-wei Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document